Taste alterations in hospitalized patients with cancer
Recruiting
- Conditions
- Cancer
- Registration Number
- NL-OMON20132
- Lead Sponsor
- MCG
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 100
Inclusion Criteria
18 years and older
- Admission to medical oncology, hematology or lung oncology wards at the UMCG
- Understanding of the Dutch language
Exclusion Criteria
Inability to judge taste alterations
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Taste alterations
- Secondary Outcome Measures
Name Time Method - Change in mouthfeeling<br>- Impact on daily life<br>- Change in basic tastes<br>
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular pathways are associated with cancer-related taste alterations in observational studies like NL-OMON20132?
Which biomarkers predict taste dysfunction severity in cancer patients during hospitalization as per MCG research?
How do taste alterations in cancer patients impact treatment adherence and nutritional outcomes in clinical settings?
What pharmacological strategies are being explored to manage taste dysfunction in oncology, compared to standard care?
Are there specific cancer subtypes with higher prevalence of taste changes in observational trials such as NL-OMON20132?